Rating History for RXi Pharmaceuticals (RXII) by Laidlaw

More Stocks Rated by Laidlaw | Latest Ratings for RXII
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/2/2014 N/A New Coverage Buy
(N/A)		 8.00
(N/A)		 2.79
(0.33)		 -88.17% Details